Brief: Nykode Therapeutics Q3 Net Loss Narrows To $10.2 Million
Nov 15 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* Q3 TOTAL REVENUE AND OTHER INCOME OF USD 2.8 MILLION,
COMPARED
TO USD 1.3 MILLION FOR THE THIRD QUARTER OF 2022
* Q3 NET LOSS OF USD 10.2 MILLION, COMPARED TO A NET LOSS OF
USD
14.9 MILLION FOR THE THIRD QUARTER OF 2022
Source text for Eikon: ID:nObiTlvq6a
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026